Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Braitsev BR. Osteodystrophia fibrosa localisata. Vestnik hirurgii i pogranichnykh oblastey. 1928;1:301-315. (in Russian).
McCune DJ, Bruch H. Osteodystrophia fibrosa: Report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin and hyperthyroidism, with a review of the literature. Am J Dis Child. 1937;54(40):806-848.
McCune DJ, Bruch H. Osteodystrophia Fibrosa. Am J Dis Child. 1937;54(40):806-848.
Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med. 1937;216(17):727-746. doi: 10.1056/nejm193704292161701.
Weinstein LS. Other skeletal diseases resulting from G protein defects – fibrous dysplasia and McCune Albright syndrome. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of Bone Biology. San Diego: Academic Press; 1996. 877-887 pp.
Khan SK, Yadav PS, Elliott G, Hu DZ, Xu R, Yang Y. Induced GnasR201H expression from the endogenous Gnas locus causes fibrous dysplasia by up-regulating Wnt/β-catenin signaling. Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E418-E427. doi: 10.1073/pnas.1714313114.
Tobar-Rubin R, Sultan D, Janevska D, et al. Intragenic suppression of a constitutively active allele of Gsα associated with McCune-Albright syndrome. J Mol Endocrinol. 2013 Feb 26;50(2):193-201. doi: 10.1530/JME-12-0087.
de Sanctis L, Galliano I, Montanari P, Matarazzo P, Tessaris D, Bergallo M. Combining Real-Time COLD- and MAMA-PCR TaqMan Techniques to Detect and Quantify R201 GNAS Mutations in the McCune – Albright Syndrome. Horm Res Paediatr. 2017;87(5):342-349. doi: 10.1159/000463384.
Cutler CM, Lee JS, Butman JA, et al. Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery. 2006 Nov;59(5):1011-7; discussion 1017-8. doi: 10.1227/01.NEU.0000254440.02736.E3.
Utriainen P, Valta H, Björnsdottir S, Mäkitie O, Horemuzova E. Polyostotic Fibrous Dysplasia With and Without McCune – Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort. Front Endocrinol (Lausanne). 2018 Mar 15;9:96. doi: 10.3389/fendo.2018.00096.
Pereira TDSF, Gomes CC, Brennan PA, Fonseca FP, Gomez RS. Fibrous dysplasia of the jaws: Integrating molecular pathogenesis with clinical, radiological, and histopathological features. J Oral Pathol Med. 2019;48(1):3-9. doi: 10.1111/jop.12797.
Mahdi AJ, Connor P, Thakur I. McCune-Albright syndrome-associated bone marrow failure and extramedullary haematopoeisis secondary to fibrous dysplasia. Br J Haematol. 2017;178(2):179. doi: 10.1111/bjh.14690.
Lecumberri B, Pozo-Kreilinger JJ, Esteban I, et al. Head and neck manifestations of an undiagnosed McCune – Albright syndrome: clinicopathological description and literature review. Virchows Arch. 2018;473(5):645-648. doi: 10.1007/s00428-018-2396-z.
Carney JA, Young WF, Stratakis CA. Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune – Albright syndrome. Am J Surg Pathol. 2011;35(9):1311-1326. doi: 10.1097/pas.0b013e31821ec4ce.
Cho EK, Kim J, Yang A, et al. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study. Orphanet J Rare Dis. 2016;11(1):113. doi: 10.1186/s13023-016-0496-x.
Corica D, Aversa T, Pepe G, De Luca F, Wasniewska M. Peculiarities of Precocious Puberty in Boys and Girls With McCune – Albright Syndrome. Front Endocrinol (Lausanne). 2018 Jun 22;9:337. doi: 10.3389/fendo.2018.00337.
Aversa T, Zirilli G, Corica D, De Luca F, Wasniewska M. Phenotypic testicular abnormalities and pubertal development in boys with McCune – Albright syndrome. Ital J Pediatr. 2018;44(1):136. doi: 10.1186/s13052-018-0577-7.
Pina Rivera Y, Rwegerera GM, Sesay S. Short stature and growth hormone deficiency: unexpected manifestations of McCune – Albright syndrome. BMJ Case Rep. 2018;2018. pii: bcr-2018-225709. doi: 10.1136/bcr-2018-225709.
Yao Y, Liu Y, Wang L. et al. Clinical characteristics and management of growth hormone excess in patients with McCune – Albright syndrome. Eur J Endocrinol. 2017;176(3):295-303. doi: 10.1530/EJE-16-0715.
Berglund JA, Tella SH, Tuthill KF, et al. Scoliosis in Fibrous Dysplasia / McCune – Albright Syndrome: Factors Associated With Curve Progression and Effects of Bisphosphonates. J Bone Miner Res. 2018;33(9):1641-1648. doi: 10.1002/jbmr.3446.
Boyce AM, Turner A, Watts L, et al. Improving patient outcomes in fibrous dysplasia / McCune – Albright syndrome: an international multidisciplinary workshop to inform an international partnership. Arch Osteoporos. 2017;12(1):21. doi: 10.1007/s11657-016-0271-6.
Agopiantz M, Journeau P, Lebon-Labich B, et al. McCune – Albright syndrome, natural history and multidisciplinary management in a series of 14 pediatric cases. Ann Endocrinol (Paris). 2016;77(1):7-13. doi: 10.1016/j.ando.2016.01.002.
Schwarze M, Weber MA, Mechtersheimer G, Lehner B, Renker EK. Mazabraud and McCune – Albright syndromes in association: A case of two very rare orthopaedic tumour entities. Orthopade. 2017;46(9):776-780. doi:10.1007/s00132-017-3399-1.
Uwaifo GI, Sarlis NJ, Scheinfeld NS. McCune – Albright Syndrome Clinical Presentation. 2018. Available from: https://www.medscape.com.